Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03762512 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Collection of Donated Placenta for Isolation of Mitochondria for Research and for Future Use in Mitochondrial Augmentation Therapies

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 13 words
  2. Enrollment target: 20 to 300v3 Show 4 more changesShow less
    • Primary completion date: Dec 2020 to Dec 2027
    • Study completion date: Dec 2024 to Mar 2028
    • Eligibility criteria expanded, about 187 words
    • Study title expanded, about 12 words
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study completion date: Dec 2020 to Dec 2024
    • Start date changed from estimate of Dec 2018 to Dec 1, 2018
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Placenta will be collected and from these, mitochondrial will be harvested. Mitochondria will be used in mitochondrial augmentation therapy.
Trial Details
NCT Number NCT03762512
Lead Sponsor Minovia Therapeutics Ltd.
Conditions
(from sponsor)		 Pregnancy Related
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov